NM_005120.3:c.4665G>A

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_005120.3(MED12):​c.4665G>A​(p.Thr1555Thr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000985 in 1,167,954 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 41 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.00011 ( 0 hom., 5 hem., cov: 21)
Exomes 𝑓: 0.000097 ( 0 hom. 36 hem. )

Consequence

MED12
NM_005120.3 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -5.24

Publications

0 publications found
Variant links:
Genes affected
MED12 (HGNC:11957): (mediator complex subunit 12) The initiation of transcription is controlled in part by a large protein assembly known as the preinitiation complex. A component of this preinitiation complex is a 1.2 MDa protein aggregate called Mediator. This Mediator component binds with a CDK8 subcomplex which contains the protein encoded by this gene, mediator complex subunit 12 (MED12), along with MED13, CDK8 kinase, and cyclin C. The CDK8 subcomplex modulates Mediator-polymerase II interactions and thereby regulates transcription initiation and reinitation rates. The MED12 protein is essential for activating CDK8 kinase. Defects in this gene cause X-linked Opitz-Kaveggia syndrome, also known as FG syndrome, and Lujan-Fryns syndrome. [provided by RefSeq, Aug 2009]
MED12 Gene-Disease associations (from GenCC):
  • FG syndrome 1
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Orphanet
  • MED12-related intellectual disability syndrome
    Inheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
  • X-linked intellectual disability with marfanoid habitus
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Orphanet
  • blepharophimosis - intellectual disability syndrome, MKB type
    Inheritance: XL Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet
  • cholestasis-pigmentary retinopathy-cleft palate syndrome
    Inheritance: XL Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.66).
BP6
Variant X-71134404-G-A is Benign according to our data. Variant chrX-71134404-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 382577.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-71134404-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 382577.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-71134404-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 382577.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-71134404-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 382577.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-71134404-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 382577.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-71134404-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 382577.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-71134404-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 382577.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-71134404-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 382577.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-71134404-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 382577.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-71134404-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 382577.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-71134404-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 382577.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-71134404-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 382577.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-71134404-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 382577.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-5.24 with no splicing effect.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.000109 (12/110211) while in subpopulation SAS AF = 0.000783 (2/2555). AF 95% confidence interval is 0.000139. There are 0 homozygotes in GnomAd4. There are 5 alleles in the male GnomAd4 subpopulation. Median coverage is 21. This position passed quality control check.
BS2
High Hemizygotes in GnomAd4 at 5 XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MED12NM_005120.3 linkc.4665G>A p.Thr1555Thr synonymous_variant Exon 34 of 45 ENST00000374080.8 NP_005111.2 Q93074-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MED12ENST00000374080.8 linkc.4665G>A p.Thr1555Thr synonymous_variant Exon 34 of 45 1 NM_005120.3 ENSP00000363193.3 Q93074-1

Frequencies

GnomAD3 genomes
AF:
0.000109
AC:
12
AN:
110211
Hom.:
0
Cov.:
21
show subpopulations
Gnomad AFR
AF:
0.000133
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000783
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000114
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000104
AC:
13
AN:
125092
AF XY:
0.000168
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000477
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000587
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000974
AC:
103
AN:
1057743
Hom.:
0
Cov.:
29
AF XY:
0.000105
AC XY:
36
AN XY:
342341
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
25150
American (AMR)
AF:
0.0000339
AC:
1
AN:
29515
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
18669
East Asian (EAS)
AF:
0.00
AC:
0
AN:
27676
South Asian (SAS)
AF:
0.000459
AC:
23
AN:
50115
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
38233
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4061
European-Non Finnish (NFE)
AF:
0.0000964
AC:
79
AN:
819750
Other (OTH)
AF:
0.00
AC:
0
AN:
44574
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.479
Heterozygous variant carriers
0
4
8
11
15
19
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000109
AC:
12
AN:
110211
Hom.:
0
Cov.:
21
AF XY:
0.000154
AC XY:
5
AN XY:
32467
show subpopulations
African (AFR)
AF:
0.000133
AC:
4
AN:
30186
American (AMR)
AF:
0.00
AC:
0
AN:
10367
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2636
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3504
South Asian (SAS)
AF:
0.000783
AC:
2
AN:
2555
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
5791
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
239
European-Non Finnish (NFE)
AF:
0.000114
AC:
6
AN:
52766
Other (OTH)
AF:
0.00
AC:
0
AN:
1481
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.489
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.0000793

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Familial thoracic aortic aneurysm and aortic dissection Benign:1
Feb 19, 2018
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

FG syndrome Benign:1
Dec 10, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
Jan 18, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.66
CADD
Benign
0.49
DANN
Benign
0.69
PhyloP100
-5.2
Mutation Taster
=80/20
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs375001801; hg19: chrX-70354254; COSMIC: COSV61357694; COSMIC: COSV61357694; API